Pink Sheet
Scrip
Medtech Insight
HBW Insight
Generics Bulletin
In Vivo
Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Trump’s US FDA User Fee Cycle: ‘An Underappreciated Threat’
Nov 16 2024
•
By
Sarah Karlin-Smith
President-elect Trump did not have full control of a user fee cycle during his first term, but will during his upcoming second term.
(Shutterstock)
Learn what's happening at the US FDA. On the go.
Derrick Gingery and the team bring you a weekly "Drug Fix".
More from User Fees
More from Elections